Reported 100% of Acute Myeloid Leukemia (AML) patients treated in INB-100 remain in complete remission (CR) at the 2024 European Hematology Association Congress and received FDA guidance for a future ...

" I’m honored to join Innate Pharma at such a pivotal moment in its evolution,”said Jonathan Dickinson, Chief Executive Officer of Innate Pharma. “ We achieved notable regul ...

Reported 100% of Acute Myeloid Leukemia (AML) patients treated in INB-100 remain in complete remission (CR) at the 2024 European Hematology ...

Increasing concerns over clinicians' risks of developing cancer or other health problems from ionizing radiation exposures on ...

We’re thrilled to welcome Ned, a distinguished oncologist, accomplished scientist and seasoned public servant, to our Board of Directors,” said Patrick Roberts, Pharm.D., Ph.D., Chief Executive ...

As patient advocates and groups sound the alarm, a Kansas expert said one thing remains critical for women to have the best ...

The findings come out of the first two years of a five-year, real-world study, which was published today in the Journal of Clinical Oncology - Oncology Practice (JCO-OP). Through a novel approach, the ...

"Despite how they're being marketed and perceived by the public, these water bead gel blasters can have devastating ...

ASCO-ONS standards for the administration of antineoplastic therapy provide a framework for ensuring patient safety.

The ASCO-ONS standards for administration of antineoplastic therapy provide a comprehensive framework for ensuring patient ...

A gene drive to treat herpes, improving clinical trials for immunocompromised people — and Breast Sexual Health Clinic opens.

In this on-demand webinar series, CURE partnered with City of Hope to discuss effective communication when making treatment ...